Jefferies Group LLC - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 72 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$83,000
-46.5%
26,383
-47.2%
0.00%
-100.0%
Q2 2016$155,000
-19.3%
50,000
-50.0%
0.00%0.0%
Q3 2014$192,000
+12.9%
100,000
+100.0%
0.00%0.0%
Q2 2014$170,000
+1.2%
50,0000.0%0.00%
-50.0%
Q1 2014$168,000
-45.3%
50,000
-50.0%
0.00%0.0%
Q4 2013$307,000
-23.6%
100,0000.0%0.00%
-50.0%
Q3 2013$402,000100,0000.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,250,000$1,975,0001.00%
Broadfin Capital, LLC 3,567,624$5,636,0000.24%
Abingworth LLP 437,994$679,0000.19%
GREAT POINT PARTNERS LLC 250,000$395,0000.19%
Rhenman & Partners Asset Management AB 400,000$632,0000.18%
BVF INC/IL 559,624$884,0000.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$2,673,0000.10%
Perceptive Advisors 503,156$795,0000.07%
Gruss Capital Management LP 960,000$1,517,0000.04%
Spark Investment Management LLC 103,400$160,0000.03%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders